BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 25550862)

  • 1. Uterine smooth muscle tumors of uncertain malignant potential (STUMP): pathology, follow-up and recurrence.
    Dall'Asta A; Gizzo S; Musarò A; Quaranta M; Noventa M; Migliavacca C; Sozzi G; Monica M; Mautone D; Berretta R
    Int J Clin Exp Pathol; 2014; 7(11):8136-42. PubMed ID: 25550862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uterine smooth muscle tumors of uncertain malignant potential (STUMP): a clinicopathologic analysis of 16 cases.
    Ip PP; Cheung AN; Clement PB
    Am J Surg Pathol; 2009 Jul; 33(7):992-1005. PubMed ID: 19417585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience of uterine smooth muscle tumor of uncertain malignant potential in two gynecological centers: Oncological and obstetrical aspects.
    Shim JI; Han AKW; Jeon HJ; Kim ML; Jung YW; Yun BS; Seong SJ; Shin E; Cho YJ; Rha SH
    Eur J Obstet Gynecol Reprod Biol; 2020 Mar; 246():7-13. PubMed ID: 31927240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of morcellation of uterine smooth muscle tumor of uncertain malignant potential and endometrial stromal sarcoma: case series and recommendations for clinical practice.
    Mowers EL; Skinner B; McLean K; Reynolds RK
    J Minim Invasive Gynecol; 2015; 22(4):601-6. PubMed ID: 25596464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine smooth muscle tumor of uncertain malignant potential: fertility and clinical outcomes.
    Şahin H; Karatas F; Coban G; Özen Ö; Erdem Ö; Onan MA; Ayhan A
    J Gynecol Oncol; 2019 Jul; 30(4):e54. PubMed ID: 31074239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic evaluation of uterine smooth muscle tumors of uncertain malignant potential (STUMP): A single center experience.
    Karataşlı V; Çakır İ; Ayaz D; Budak A; Sancı M
    J Gynecol Obstet Hum Reprod; 2019 Oct; 48(8):637-642. PubMed ID: 30898630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Smooth muscle tumor of uncertain malignant potential (STUMP)--clinico-pathomorphological analysis of the cases and literature review].
    Dańska-Bidzińska A; Bakuła-Zalewska E; Nasierowska-Guttmejer A; Kowalewska M; Barnaś E; Sobiczewski P; Bidziński M
    Ginekol Pol; 2012 Jun; 83(6):412-6. PubMed ID: 22880459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinicopathologic review and obstetric outcome of uterine smooth muscle tumor of uncertain malignant potential (STUMP) in a single institution.
    Ha HI; Choi MC; Heo JH; Kim KA; Jung SG; Park H; Joo WD; Song SH; Kim TH; Lee C
    Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():1-5. PubMed ID: 29902779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Clinicopathological Study of 21 Cases With Uterine Smooth Muscle Tumors of Uncertain Malignant Potential: Centralized Review Can Purify the Diagnosis.
    Basaran D; Usubutun A; Salman MC; Narin MA; Boyraz G; Turkmen O; Comert Kimyon G; Karalok A; Bulbul D; Turan T; Ozgul N; Yuce K
    Int J Gynecol Cancer; 2018 Feb; 28(2):233-240. PubMed ID: 29303932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uterine smooth muscle tumor of uncertain malignant potential: a retrospective analysis.
    Guntupalli SR; Ramirez PT; Anderson ML; Milam MR; Bodurka DC; Malpica A
    Gynecol Oncol; 2009 Jun; 113(3):324-6. PubMed ID: 19342083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uterine smooth muscle tumors of uncertain malignant potential (STUMP): A retrospective study in a single center.
    Zhang C; Gao J; Lu S; Zhang Y; Zhu H
    Eur J Obstet Gynecol Reprod Biol; 2021 Oct; 265():74-79. PubMed ID: 34467879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uterine smooth muscle tumors of uncertain malignant potential: a case presentation.
    Gezginç K; Yazici F; Tavli L
    Int J Clin Oncol; 2011 Oct; 16(5):592-5. PubMed ID: 21225306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uterine smooth muscle tumors of unknown malignant potential: A challenging question.
    Gadducci A; Zannoni GF
    Gynecol Oncol; 2019 Sep; 154(3):631-637. PubMed ID: 31326137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential.
    O'Neill CJ; McBride HA; Connolly LE; McCluggage WG
    Histopathology; 2007 Jun; 50(7):851-8. PubMed ID: 17543074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of P16 and P21 in benign and malignant uterine smooth muscle tumors.
    Ünver NU; Acikalin MF; Öner Ü; Ciftci E; Ozalp SS; Colak E
    Arch Gynecol Obstet; 2011 Aug; 284(2):483-90. PubMed ID: 20878171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
    Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
    J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uterine smooth muscle tumor analysis by comparative genomic hybridization: a useful diagnostic tool in challenging lesions.
    Croce S; Ribeiro A; Brulard C; Noel JC; Amant F; Stoeckle E; Devouassoux-Shisheborah M; Floquet A; Arnould L; Guyon F; Mishellany F; Garbay D; Cuppens T; Zikan M; Leroux A; Frouin E; Duvillard P; Terrier P; Farre I; Valo I; MacGrogan GM; Chibon F
    Mod Pathol; 2015 Jul; 28(7):1001-10. PubMed ID: 25932961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential role of BCL2 in the recurrence of uterine smooth muscle tumors of uncertain malignant potential.
    Conconi D; Chiappa V; Perego P; Redaelli S; Bovo G; Lavitrano M; Milani R; Dalprà L; Lissoni AA
    Oncol Rep; 2017 Jan; 37(1):41-47. PubMed ID: 28004108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinicopathologic study of uterine smooth muscle tumours of uncertain malignant potential (STUMP).
    Ng JS; Han A; Chew SH; Low J
    Ann Acad Med Singap; 2010 Aug; 39(8):625-8. PubMed ID: 20838704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncologic and Reproductive Outcomes of Uterine Smooth Muscle Tumor of Uncertain Malignant Potential: A Single Center Retrospective Study of 67 Cases.
    Huo L; Wang D; Wang W; Cao D; Yang J; Wu M; Yang J; Xiang Y
    Front Oncol; 2020; 10():647. PubMed ID: 32477938
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.